
Brain diseases and disorders are the leading cause of disability in the country, directly affecting one in three Canadians as well as their family members, friends, colleagues and caregivers. Substance misuse and addictions also place a huge burden on those affected, most dramatically in Canada’s ongoing increases in terms of per capita consumption of narcotics (e.g. opioids). CAMH’s overarching strategy, Vision 2020, outlined our commitment to better understand brain structure and function to learn what causes mental illness; to improve prevention, treatment, and management of illness through clinical research; and to drive research, policy and social change by understanding societal factors that contribute to mental illness. The domains of CAMH research will drive a research agenda based on cross-disciple and cross-division “big questions” that guide our work through this research plan and future years. As an academic health sciences centre, CAMH’s core mandate is to provide the best care for the patients of today, as well as hope for the future. Research generates knowledge for CAMH and beyond, and provides this hope.

Harness our unique set of resources—scientific expertise, access to patients and community, collaborative partnerships and the capacity for large-scale and longitudinal studies—to focus on the most important and relevant questions that will contribute to a greater understanding of the healthy brain, the pathophysiologies of brain illness and the progression to illness. Change our view of the brain as a set of information-processing circuits. We will study and disseminate a modernized conceptualization of mental illness that links to perspectives from the brain, the rest of the body, the social context and environment, and the lifespan. Work towards correcting the scarcity of novel treatments.



Create a dynamic system where research questions are identified and knowledge is developed in collaboration among stakeholders, including people with lived experience, patients, family members, community partners, clinicians, front-line staff and scientists. Everyone working at or connected with CAMH will be a part of our knowledge development and discovery. Patients will experience CAMH care as informed, empowering and optimistic, and will see their value in partnering and contributing to research that will create hope, recovery and cures for people with their conditions.



Drive the translation of research evidence towards influencing prevention, early risk assessment, non-invasive and meaningful diagnostic tests, and curative or ongoing treatments that maximize quality of life. Build upon our current research expertise with communities, populations, global health and health systems to develop and evaluate prevention and intervention initiatives. Explore genetic-based underpinnings to further our understanding of suicide.


Specializing in genetic and molecular bases of mental illness and their treatments.
Research Imaging Centre is the first in the world fully dedicated to mental illness research.
Identified 26 new genes linked to intellectual disability.
Temerty Centre for Therapeutic Brain Intervention established the largest brain stimulation centre in Canada.
Advised the federal government on the legalization of cannabis.
A Leader in Mental Health Research
Longest ongoing drug, alcohol and mental health student surveys in Canada.
Inception of the Krembil Centre for Neuroinformatics—harnessing the power of high-performance data computing.
Selected as the Ontario hub for research into opioid misuse.
Largest pool of DNA collected by any mental health institution globally.
Global studies on the burden of mental illness.
Centre for Addiction and Mental Health
33 Russell Street, Room T100
Toronto, ON M5S 2S1
Email: research@camh.ca
Website: www.camh.ca/en/research
Subscribe to our e-newsletter: CAMH Discovers
Search for Research Studies: CAMH Research Connect

